Skip to content

Covista

US · CVSA #2249 by market cap Listed 1970
127.30 -0.07 -0.06%
Live - 5344 symbols - heartbeat 220s ago · 2026-10-08 07:00
Pre-market 127.39 +0.07%
After-hours 127.30 0.00%
Market cap
4.31B
P/B
2.98
EPS
7.04
Reader sentiment Are you bullish or bearish on CVSA?

Anonymous reader poll. Unscientific, not investment advice.

Valuation each multiple against its own 5-year range

P/B ratio 2.98 Expensive vs history 92nd percentile
5-year average 1.59 · #32 of 41 in Education & Training Services
P/E ratio 18.09 In line with history 57th percentile
5-year average -37.32 · forward 14.22 · #17 of 25 in Education & Training Services
P/S ratio 2.21 Expensive vs history 93rd percentile
5-year average 1.44 · forward 2.08 · #35 of 44 in Education & Training Services

Vs. peers Education & Training Services

Company Market cap P/E (TTM) P/B Div yield
Covista (CVSA) 4.31B 18.08 2.98 0.00%
New Oriental (EDU) 8.88B 19.10 2.23 2.09%
TAL Education (TAL) 7.08B 7.99 1.73 0.00%
Laureate Education (LAUR) 5.31B 17.45 4.65 0.00%
Grand Canyon Education (LOPE) 4.06B 18.80 6.06 0.00%
Stride (LRN) 3.31B 11.15 2.03 0.00%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★★★ Fair value161.30 Economic moatNone UncertaintyMedium

Trading 26.7% below Morningstar's fair value estimate.

Fair value

Covista Inc is assigned a 5-star quantitative star rating, illustrating our stance that this share class offers a compelling opportunity for investors. The stock currently trades at a 22% discount to our quantitative fair value estimate of $161.30 per share; however, some caution is warranted due to this estimate's medium uncertainty rating.

The company's profitability strengthens our fair value estimate. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. Reflecting the firm's profitability is its earnings yield of 6.6%, which sits in the top 40% compared with peers globally. This suggests that it is generating substantial earnings relative to its share price, which contributes to our view that shares are cheap.

Alternatively, the firm's balance sheet is potentially concerning. Excessive leverage heightens financial risk, potentially undermining a firm's value. The firm's EBITDA/interest coverage ratio of 11.8, for example, ranks in the bottom 50% globally. This gives us pause, as it can be a warning sign of financial distress if conditions don't improve. Despite our favorable price/fair value ratio, this characteristic is a negative attribute.

Economic moat

With its quantitative economic moat rating of none, this business is unlikely to consistently outearn its cost of capital without structural protection from competition. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-08 07:00:00 · For reference only, not investment advice and not tailored to your situation.